SCHEMBL19080061

SCHEMBL19080061

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)c5ccccc5c5c6oc6c7ccccc7c7ccccc7c65)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.38
ACMSD Q8TDX5 1/20 0.38
ARSA P15289 1/20 0.38
CDC25A P30304 1/20 0.38
CDC25C P30307 1/20 0.38
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
ENPP3 O14638 1/20 0.35
ENPP1 P22413 1/20 0.35
ALOX5 P09917 1/20 0.35
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
SOS1 Q07889 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080055 0.92 ARSA (0.43) MCL1ACMSDARSACDC25ACDC25C
SCHEMBL19080054 0.91 ALOX5 (0.37) MCL1ACMSDARSACDC25ACDC25C
SCHEMBL19079969 0.91 CA12 (0.36) MCL1ACMSDARSACDC25ACDC25C
SCHEMBL17945166 0.90 ALOX5 (0.43) MCL1ACMSDARSACDC25ACDC25C
SCHEMBL19080077 0.88 CYP1A1 (0.38) ARSACDC25ACDC25CALDH1A1HSD17B10
SCHEMBL19080053 0.88 ALOX5 (0.36) MCL1ACMSDARSACDC25ACDC25C
SCHEMBL19080060 0.87 ARSA (0.43) ARSACDC25ACDC25CALDH1A1HSD17B10
SCHEMBL19080093 0.87 CYP1A1 (0.39) ARSACDC25ACDC25CALDH1A1HSD17B10
SCHEMBL17943909 0.87 ALOX5 (0.42) MCL1ACMSDARSACDC25ACDC25C
SCHEMBL17945177 0.87 ALOX5 (0.39) MCL1ACMSDARSACDC25ACDC25C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 MCL1 1092/4885ACMSD 1768/4885ARSA 4452/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 MCL1 1092/4885ACMSD 1768/4885ARSA 4452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.